October 22, 2022

Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5

Key Points

Key points are not available for this paper at this time.

Abstract

Our experience supports the use of systemic BIV and SBPS as a method to avoid heparin exposure in a patient population predisposed to the development of HIT.

Bookmark

Cite This Study

Bashline et al. (Sat,) studied this question.

synapsesocial.com/papers/69cec487cfec6ed4b8c51ec4 https://doi.org/https://doi.org/10.1111/aor.14428

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Heparin-Induced Thrombocytopenia under Mechanical Circulatory Support by Large Impella for Acute Cardiogenic Shock2021 · 14 citations
2Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation2011 · 229 citations
3Utilization and Outcomes of Temporary Mechanical Circulatory Support Devices in Cardiogenic Shock2019 · 12 citations
4Bicarbonate Purge Solution to Support Impella Devices for Patients with Clinically Suspected or Confirmed Heparin-induced Thrombocytopenia2021 · 4 citations
5Use of an argatroban-based purge solution in a percutaneous ventricular assist device2017 · 31 citations